ADVERTISEMENT
Genomic Driven Artificial Intelligence Based System to Detect and Diagnose Lobular Carcinoma
Featuring Fresia Pareja, MD, PhD
Fresia Pareja, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, New York, discussed novel mechanisms of CDH1 inactivation discovered using an artificial intelligence based system built to detect and diagnose lobular carcinoma.
These results were first reported at the 2023 San Antonio Breast Cancer Symposium.
Source:
Pareja F, Dopeso H, Wang Y, et al. Novel mechanisms of CDH1 inactivation in breast invasive lobular carcinoma unveiled by the integration of artificial intelligence and genomics. Presented at the 2023 San Antonio Breast Cancer Symposium; December 5-9; San Antonio, Texas. Abstract GS03-04
© 2023 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Oncology Learning Network or HMP Global, their employees, and affiliates.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement